Effects of systemic octreotide, local mytomycine-C and local corticosteroids on wound-healing reaction after glaucoma surgery

International Ophthalmology

Volumn 24, Issue 5, 2001, Pages 235-241

  Akyol, Nuray ^a   Demir, Tamer ^a   Kükner, Aysel ^a   Çolakoǧlu, Neriman ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Glaucoma filtration surgery; Octreotide; Wound healing modulation

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE SODIUM PHOSPHATE; GENTAMICIN; GLUTARALDEHYDE; MITOMYCIN C; OCTREOTIDE; OXYTETRACYCLINE; POLYMYXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONJUNCTIVA; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; FIBROBLAST; GLAUCOMA SURGERY; MACROPHAGE; MALE; NONHUMAN; RABBIT; STATISTICAL SIGNIFICANCE; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANIMALS; CILIARY BODY; CONJUNCTIVA; FIBROBLASTS; FILTERING SURGERY; GLAUCOMA; HORMONES; INJECTIONS, SUBCUTANEOUS; INTRAOPERATIVE CARE; MACROPHAGES; MALE; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; OCTREOTIDE; OPHTHALMIC SOLUTIONS; POSTOPERATIVE CARE; RABBITS; WOUND HEALING;

EID: 0141608081     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025401430745     Document Type: Article

References (25)

1. Khaw PT, Occleston NL, Schultz GS, Grierson I, Sherwood MB, Larkin G. Activation and supression of fibroblast function. Eye 1994; 8: 188-195.
2. Joseph JP, Miller MH, Hitchings RA. Wound healing as a barrier to successful filtration surgery. Eye 1988; 2(Suppl): S113-S123.
3. Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surgery 1993; 24: 152-170.
4. Cunliffe IA, Rees RC, Rennie IG. The effect of TGF-beta1 and TGF-beta2 on the proliferation of human Tenon's capsule fibroblasts in tissue culture. Acta Ophthalmol Scand 1996; 74: 31-35.
5. Joseph JP, Grierson I, Hitchings RA. Normal rabbit aqueous humour, fibronectin and fibroblast conditioned medium are chemoattractant to Tenon's capsule fibroblasts. Eye 1987; 1: 585-592.
6. Kook MS, Lee DA. Improving the success of glaucoma surgery by controlling wound healing. Ophthalmol Clin North America 1995; 8: 393-399.
7. Khaw PT, Wilkins M. Antifibrotic agents in glaucoma surgery. In: Yanoff M, Duker JS, eds. Ophthalmology, Ch 12. London: Mosby, 1999, 31.1.
8. Bauer W, Briner U, Doepfner W. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982; 31: 1131-1140.
9. Lamberts SW, Van Der Dely AJ, De Harder WW, Hofland L. Octreotide. N Engl J Med 1996; 334: 246-254.
10. Gry KE, Meer R. Pharmacodynamic effects of sandostatin in the gastrointestinal tract. Digestion 1993; 54: 14-19.
11. Danesi R, Agen C, Benelli U, Di Paola A, Nardini D, Bocci G, Basolo F, Campagni A, Del Tacca M. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clinical Cancer Research 1997; 3: 265-272.
12. Miller MH, Grierson I, Unger WI, Hitchings RA. Wound healing in animal model of glaucoma fistulizing surgery in the rabbit. Opthal Surg 1989; 20: 350.
13. Nuyts RMMA, Felten PC, Pels E, Langerhorst CT, Geijssen HC, Grossniklaus HE, Greve EL. Histopathologic effects of mitomycin-C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol 1994; 118: 225-237.
14. Heaps RS, Nordlund JR, Fernandez-Gonzalez F, Redick JA, Conway BP. Ultrastructural changes in rabbit ciliary body after extraocular mitomycin C. Invest Ophthalmol Vis Sci 1998; 39: 1971-1975.
15. Occleston NL, Daniels JT, Tarnuzzer RW, Sethi KK, Alexander RA, Bhaftacharya SS, Schultz GS, Khaw PT. Single exposures to antiproliferatives: Long term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci 1997; 38: 1998-2007.
16. Ferone D, Van Hagen PM, Van Koetsveld PM, Zuijderwijk J, Mooy DM, Lichtenauer-Kaligis EG, Colao A, Bogers AJ, Lombard G, Lamberts SW, Hofland U. In vitro characterisation of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinol 1999; 140: 373-380.
17. Gaudillere A, Bernard C, Abello J, Schmitt D, Claudy A, Misery L. Human normal dermal fibroblasts express somatostatin receptors. Exp Dermatol 1999; 8: 267-273.
18. Davis MI, Wilson SH, Grant MB. The therapeutic problem of proliferative diabetic retinopathy: Targeting somatostatin receptors. Horm Metab Res 2001; 33(5): 295-299.
19. Lai HS, Chen Y. Effect of octreotide on postoperative intraperitoneal adhesions in rats. Scand J Gastroenterol 1996; 31: 678-681.
20. Baykal A, Özdemir A, Rena N, Korkmaz A, Sayek I. The effect of octreotide on postoperative adhesion formation. Can J Surg 2000; 43: 43-47.
21. Alper D, Levy A, Kadouri A, Abarbanel J, Chaimoff C, Kyzer S. The effect of octreotide on wound healing: An in vitro and in vivo experimental study. Eur J Surg 1997; 163: 773-777.
22. Matucci-Cennic M, Borrelli F, Generini S et al. Somatostatin induced modulation of inflammation in experimental arthritis. Arthritis Rheum 1995; 38: 1687-1693.
23. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: A new glaucoma antiscarring agent. Invest Ophthalmol Vis Sci 1999; 40: 2225-2234.
24. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta2. Exp Eye Res 1994; 59: 723-727.
25. Kay EP, Lee HK, Park KS, Lee SC. Indirect mitogenic effect of transforming growth factor beta on cell proliferation of subconjunctival fibroblasts. Invest Ophthalmol Vis Sci 1998; 39: 481-486.